Mounjaro (Tirzepatide) Injections 2.5mg
Effectiveness: Avg. ~22% weight loss* Dose: One weekly single dose (One pen per month) Contains Tirzepatide
✓ In Stock
Start Your Expert Consultation
Mounjaro is a once-weekly injectable pen that contains tirzepatide, a medicine shown to support weight loss by helping regulate blood sugar and reduce appetite. Clinical trials have reported up to 20% body weight reduction over 18 months. It may also be prescribed to adults with type 2 diabetes as part of an overall plan to improve metabolic health.
Mounjaro is a cold-chain medication and must be stored in the fridge (2°C to 8°C). It can be kept out of the fridge for up to 21 days, provided the temperature stays below 30°C.
We also offer alternative weight loss treatments such as Wegovy (semaglutide) and Saxenda (liraglutide), as well as the diabetes treatment Ozempic (semaglutide).
You May Also Like
View all
BPC-157 and TB-500 (20mg)
The BPC-157 and TB-500 combined formulation (20mg each) is supplied in a 40mg pre-filled research device, designed exclusively for controlled laboratory R&D use.
Glow 70mg
The Glow 70mg formulation is provided in a pre-filled research device, designed exclusively for controlled laboratory R&D applications. Each unit is securely sealed to maintain compound stability, support formulation assessments.
NAD+ (Nicotinamide Adenine Dinucleotide)
4–8 Week Supply NAD+ (Nicotinamide Adenine Dinucleotide) is often referred to as the master molecule for both brain and body health. It fuels cellular energy, supports DNA repair, and helps maintain mental clarity as you age.
Discreet delivery for peace of mind
